Skip to Content
  1. All products
  2. Fitness & Performance
  3. CJC-1295 No DAC
  4. Fitness & Performance
Pricelist: Default Pricelist Pricelist
Pricelist: Default Pricelist Pricelist
CJC-1295 No DAC

CJC-1295 No DAC

Lyophilized Vial · Subcutaneous Refrigerate 2–8°C · 18-month shelf life 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 45.00 $ 45.00

Format
💉 vial
  • Strength
Add to cart
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Growth hormone stimulation, natural GH release, muscle growth, recovery improvement, fat loss, anti-aging

CJC-1295 sin DAC, tambien conocido como GRF 1-29, es un análogo sintetico de la hormona liberadora de hormona del crecimiento (GHRH). Esta disenado para estimular la liberacion natural de GH desde la hipófisis al unirse al receptor GHRH. A diferencia de CJC-1295 con DAC, que tiene una vida media prolongada, CJC-1295 sin DAC aporta pulsos más cortos y frecuentes de GH que imitan los patrones naturales del organismo.

Clinical Indications
GH OptimizationAnti-AgingRecovery EnhancementBody CompositionSleep QualityIGF-1 Elevation
Recommended Stacking Protocols
✓
Ipamorelin
Potent combo for GH release
✓
AOD-9604
Synergistic fat-burning support
✓
Tesamorelin
Alternative GHRH protocol

Mechanism of Action - Growth Hormone Peptides Pathway

GHRH Receptor Agonism
Binds pituitary GHRH receptors to stimulate pulsatile GH secretion in a physiological pattern.
IGF-1 Elevation
Downstream GH release triggers hepatic IGF-1 for anabolic and regenerative effects.
Sleep Architecture
Timed nocturnal dosing aligns with natural GH pulses during deep sleep.
Short Half-Life
~30-min half-life maintains natural pulsatility — preferred for anti-aging daily cycling.
Starting Dose
50-100mcg up to 1-3x per day
Initiation phase for tolerance and baseline response.
Titration
100–200 mcg
Maintenance Range
200 mcg
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis típica:50-100 mcg

Frecuencia:hasta 1-3 veces por día. Mañana/Noche (se puede tomar mañana, tarde, noche)

Ciclo:Se recomiendan 8-12 semanas

Period Dose Phase Clinical Notes
Typical Dose 50-100mcg up to 1-3x per day maintenance Morning/Night. 8-12 weeks recommended cycle.
Preparation Protocol
  1. CJC-1295 se suministra como polvo liofilizado.
  2. CJC-1295 debe reconstituirse con agua bacteriostatica antes de su uso.
  3. Añadir 2.5 mL de agua bacteriostatica al vial de 10 mg. Concentracion final: 4 mg/mL.
1
Verify Lyophilized Powder
Confirm the vial contains an intact white or off-white powder cake. Check lot number and expiration date.
2
Gather Sterile Supplies
Required: bacteriostatic water (BW), 1 mL insulin syringe, alcohol swabs, sharps container. Confirm all supplies are sterile and within date.
⚠️ Use only bacteriostatic water. Standard sterile water significantly reduces peptide stability.
3
Select Reconstitution Volume
Choose BW volume based on vial size and target concentration. See Reconstitution Guide tab for exact volumes per strength.
4
Reconstitute the Vial
Wipe stopper with alcohol swab. Inject BW slowly along the glass wall — never directly onto the powder. Allow liquid to run down the sides.
⚠️ Do not shake. Gently swirl or roll between palms (30–60 sec). Shaking causes irreversible peptide degradation.
5
Inspect & Store
Solution should be clear and colorless or slightly yellow. Discard if cloudy or particulate. Store reconstituted at 2–8°C, use within 28 days. Label with date.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 2 mg
BW: 2 mL
Concentration: 1 mg/mL
Dose Units to Draw Volume (mL) Approx. Supply
100 mcg 10 0.10 mL 20 doses
200 mcg 20 0.20 mL 10 doses

Total Peptide: 10 mg
BW: 2.5 mL
Concentration: 4mg/mL
Dose Units to Draw Volume (mL) Approx. Supply
100mcg 2.5 units - 100 doses (12+ weeks)

Total Peptide: 5 mg
BW: 2 mL
Concentration: 2.5 mg/mL
Dose Units to Draw Volume (mL) Approx. Supply
100 mcg 4 0.04 mL 50 doses
200 mcg 8 0.08 mL 25 doses
Identity
  • Name: CJC-1295 No DAC (Modified GRF 1-29)
  • Product Type: Vial | Subcutaneous Injection
  • CAS Number: 863288-34-0
  • Available Strengths: 10mg
  • Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
  • Molecular Weight: 3,367.9 Da
  • Sequence / Type: Modified GHRH 1–29 analogue
  • Available Strengths: 2mg, 5mg, 10mg
Quality & Purity
  • Purity: 99%+
  • Purity: ≥ 99%
  • Endotoxin: ≤ 1 EU/mg
  • Appearance: White lyophilized powder
  • Solubility: Bacteriostatic water
Storage & Handling
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Syringe Tip: Administer subcutaneously with a 0.5mL insulin syringe
  • Pre-use Storage: -20°C (long-term) / 2–8°C (short)
  • Post-Reconstitution: 2–8°C · Up to 28 days
  • Shelf Life: 18 months from manufacture

Timing: up to1-3xper day.Morning/Night (can betaken morning,afternoon,night)

Storage: Refrigerate 2–8°C · 18-month shelf life

Frequency: Frequency:

Cycle: 8-12 weeks recommended

Injection Sites: Rotate approved injection sites to reduce local irritation risk.